RhumbLine Advisers’s KALA BIO KALA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-1,362
| Closed | -$94K | – | 3169 |
|
|
2022
Q1 | $94K | Buy |
1,362
+29
| +2% | +$2K | ﹤0.01% | 2898 |
|
|
2021
Q4 | $81K | Sell |
1,333
-1
| -0.1% | -$61 | ﹤0.01% | 2958 |
|
|
2021
Q3 | $175K | Buy |
1,334
+36
| +3% | +$4.72K | ﹤0.01% | 2930 |
|
|
2021
Q2 | $344K | Buy |
1,298
+149
| +13% | +$39.5K | ﹤0.01% | 2732 |
|
|
2021
Q1 | $387K | Buy |
1,149
+44
| +4% | +$14.8K | ﹤0.01% | 2602 |
|
|
2020
Q4 | $374K | Buy |
1,105
+57
| +5% | +$19.3K | ﹤0.01% | 2567 |
|
|
2020
Q3 | $393K | Sell |
1,048
-161
| -13% | -$60.4K | ﹤0.01% | 2401 |
|
|
2020
Q2 | $635K | Buy |
1,209
+535
| +79% | +$281K | ﹤0.01% | 2238 |
|
|
2020
Q1 | $296K | Buy |
674
+69
| +11% | +$30.3K | ﹤0.01% | 2415 |
|
|
2019
Q4 | $112K | Buy |
605
+34
| +6% | +$6.29K | ﹤0.01% | 2865 |
|
|
2019
Q3 | $109K | Buy |
571
+44
| +8% | +$8.4K | ﹤0.01% | 2872 |
|
|
2019
Q2 | $168K | Buy |
527
+138
| +35% | +$44K | ﹤0.01% | 2833 |
|
|
2019
Q1 | $161K | Buy |
389
+84
| +28% | +$34.8K | ﹤0.01% | 2795 |
|
|
2018
Q4 | $75K | Buy |
+305
| New | +$75K | ﹤0.01% | 2911 |
|
|
2018
Q3 | – | Sell |
-216
| Closed | -$148K | – | 2927 |
|
|
2018
Q2 | $148K | Buy |
+216
| New | +$148K | ﹤0.01% | 2807 |
|